Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Arsenic Drinking Water Violations Decreased across the United States Following Revision of the Maximum Contaminant Level.

Foster SA, Pennino MJ, Compton JE, Leibowitz SG, Kile ML.

Environ Sci Technol. 2019 Oct 1;53(19):11478-11485. doi: 10.1021/acs.est.9b02358. Epub 2019 Sep 10.

PMID:
31502444
2.

Predicting initiation of preventive migraine medications: exploratory study in a large U.S. medical claims database.

Ford JH, Schroeder K, Buse DC, Joshi S, Gelwicks S, Foster SA, Aurora SK.

Curr Med Res Opin. 2019 Sep 9:1-11. doi: 10.1080/03007995.2019.1657716. [Epub ahead of print]

PMID:
31422701
3.

Fundamental principles of rehabilitation and musculoskeletal tissue healing.

Kirkby Shaw K, Alvarez L, Foster SA, Tomlinson JE, Shaw AJ, Pozzi A.

Vet Surg. 2019 Jul 4. doi: 10.1111/vsu.13270. [Epub ahead of print]

PMID:
31271225
4.

Treatment patterns and predictors of costs among patients with migraine: evidence from the United States medical expenditure panel survey.

Ford JH, Ye W, Nichols RM, Foster SA, Nelson DR.

J Med Econ. 2019 Sep;22(9):849-858. doi: 10.1080/13696998.2019.1607358. Epub 2019 May 8.

PMID:
30977712
5.

Replicated evolutionary inhibition of a complex ancestral behaviour in an adaptive radiation.

Foster SA, O'Neil S, King RW, Baker JA.

Biol Lett. 2019 Jan 31;15(1):20180647. doi: 10.1098/rsbl.2018.0647.

6.

Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine.

Ford JH, Foster SA, Stauffer VL, Ruff DD, Aurora SK, Versijpt J.

Patient Prefer Adherence. 2018 Nov 13;12:2413-2424. doi: 10.2147/PPA.S182563. eCollection 2018.

7.

Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors.

Yen I, Shanahan F, Merchant M, Orr C, Hunsaker T, Durk M, La H, Zhang X, Martin SE, Lin E, Chan J, Yu Y, Amin D, Neve RM, Gustafson A, Venkatanarayan A, Foster SA, Rudolph J, Klijn C, Malek S.

Cancer Cell. 2018 Oct 8;34(4):611-625.e7. doi: 10.1016/j.ccell.2018.09.002.

8.

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.

Marty FM, Winston DJ, Chemaly RF, Mullane KM, Shore TB, Papanicolaou GA, Chittick G, Brundage TM, Wilson C, Morrison ME, Foster SA, Nichols WG, Boeckh MJ; SUPPRESS Trial Clinical Study Group.

Biol Blood Marrow Transplant. 2019 Feb;25(2):369-381. doi: 10.1016/j.bbmt.2018.09.038. Epub 2018 Oct 4.

9.

Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.

Gilligan AM, Foster SA, Sainski-Nguyen A, Sedgley R, Smith D, Morrow P.

J Occup Environ Med. 2018 Dec;60(12):1120-1127. doi: 10.1097/JOM.0000000000001450.

PMID:
30199470
10.

Evolution of steroid hormones in reproductive females of the threespine stickleback fish.

Graham MA, Earley RL, Baker JA, Foster SA.

Gen Comp Endocrinol. 2018 Nov 1;268:71-79. doi: 10.1016/j.ygcen.2018.08.003. Epub 2018 Aug 2.

PMID:
30077793
11.

Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs.

Ford JH, Schroeder K, Nyhuis AW, Foster SA, Aurora SK.

J Manag Care Spec Pharm. 2019 Jan;25(1):46-59. doi: 10.18553/jmcp.2018.18058. Epub 2018 Jul 25.

13.

The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.

Foster SA, Parker S, Lanier R.

Viruses. 2017 Oct 30;9(11). pii: E320. doi: 10.3390/v9110320.

14.

Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.

Feldman SR, Foster SA, Zhu B, Burge R, Al Sawah S, Goldblum OM.

J Drugs Dermatol. 2017 Dec 1;16(12):1246-1252.

PMID:
29240860
15.

Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis.

Al Sawah S, Foster SA, Burge R, Amato D, Schacht A, Zhu B, Hartz S, Leonardi C.

J Med Econ. 2017 Dec;20(12):1224-1230. doi: 10.1080/13696998.2017.1362413. Epub 2017 Aug 22.

PMID:
28760056
16.

Tissue-Specific Mutations in BRAF and EGFR Necessitate Unique Therapeutic Approaches.

Foster SA, Klijn C, Malek S.

Trends Cancer. 2016 Dec;2(12):699-701. doi: 10.1016/j.trecan.2016.10.015. Epub 2016 Nov 21.

PMID:
28741516
17.

Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.

Al Sawah S, Foster SA, Goldblum OM, Malatestinic WN, Zhu B, Shi N, Song X, Feldman SR.

J Med Econ. 2017 Sep;20(9):982-990. doi: 10.1080/13696998.2017.1345749. Epub 2017 Jul 11.

PMID:
28635342
18.

Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.

Grossi IM, Foster SA, Gainey MR, Krile RT, Dunn JA, Brundage T, Khouri JM.

Antiviral Res. 2017 Jul;143:278-286. doi: 10.1016/j.antiviral.2017.04.002. Epub 2017 Apr 7.

PMID:
28392420
19.

The RAS/MAPK Axis Gets Stressed Out.

Foster SA, Malek S.

Mol Cell. 2016 Dec 1;64(5):854-855. doi: 10.1016/j.molcel.2016.11.024.

20.

Assessment of novel digital and smartphone goniometers for measurement of canine stifle joint angles.

Freund KA, Kieves NR, Hart JL, Foster SA, Jeffery U, Duerr FM.

Am J Vet Res. 2016 Jul;77(7):749-55. doi: 10.2460/ajvr.77.7.749.

PMID:
27347828
21.

The caregiver burden in lupus: findings from UNVEIL, a national online lupus survey in the United States.

Al Sawah S, Daly RP, Foster SA, Naegeli AN, Benjamin K, Doll H, Bond G, Moshkovich O, Alarcón GS.

Lupus. 2017 Jan;26(1):54-61. Epub 2016 May 28.

PMID:
27235701
22.

Is neighbourhood access to tobacco outlets related to smoking behaviour and tobacco-related health outcomes and hospital admissions?

Barnes R, Foster SA, Pereira G, Villanueva K, Wood L.

Prev Med. 2016 Jul;88:218-23. doi: 10.1016/j.ypmed.2016.05.003. Epub 2016 May 3.

23.

Acute systemic DNA damage in youth does not impair immune defense with aging.

Pugh JL, Foster SA, Sukhina AS, Petravic J, Uhrlaub JL, Padilla-Torres J, Hayashi T, Nakachi K, Smithey MJ, Nikolich-Žugich J.

Aging Cell. 2016 Aug;15(4):686-93. doi: 10.1111/acel.12478. Epub 2016 Apr 13.

24.

Patient Characteristics, Health Care Resource Utilization, and Costs Associated with Treatment-Regimen Failure with Biologics in the Treatment of Psoriasis.

Foster SA, Zhu B, Guo J, Nikai E, Ojeh C, Malatestinic W, Goldblum O, Kornberg LJ, Wu JJ.

J Manag Care Spec Pharm. 2016 Apr;22(4):396-405. doi: 10.18553/jmcp.2016.22.4.396.

25.

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2.

Foster SA, Whalen DM, Özen A, Wongchenko MJ, Yin J, Yen I, Schaefer G, Mayfield JD, Chmielecki J, Stephens PJ, Albacker LA, Yan Y, Song K, Hatzivassiliou G, Eigenbrot C, Yu C, Shaw AS, Manning G, Skelton NJ, Hymowitz SG, Malek S.

Cancer Cell. 2016 Apr 11;29(4):477-493. doi: 10.1016/j.ccell.2016.02.010. Epub 2016 Mar 17.

26.

Life-history plasticity in female threespine stickleback.

Baker JA, Wund MA, Heins DC, King RW, Reyes ML, Foster SA.

Heredity (Edinb). 2015 Oct;115(4):322-34. doi: 10.1038/hdy.2015.65. Epub 2015 Aug 19. Review.

27.
28.

Iterative development and the scope for plasticity: contrasts among trait categories in an adaptive radiation.

Foster SA, Wund MA, Graham MA, Earley RL, Gardiner R, Kearns T, Baker JA.

Heredity (Edinb). 2015 Oct;115(4):335-48. doi: 10.1038/hdy.2015.66. Epub 2015 Aug 5. Review.

29.

Evolutionary Influences of Plastic Behavioral Responses Upon Environmental Challenges in an Adaptive Radiation.

Foster SA, Wund MA, Baker JA.

Integr Comp Biol. 2015 Sep;55(3):406-17. doi: 10.1093/icb/icv083. Epub 2015 Jul 10. Review.

30.

Effects of Obesity on Health Related Quality of Life Following Total Hip Arthroplasty.

Foster SA, Hambright DS, Antoci V, Greene ME, Malchau H, Kwon YM.

J Arthroplasty. 2015 Sep;30(9):1551-4. doi: 10.1016/j.arth.2015.03.023. Epub 2015 Mar 31.

PMID:
25887700
31.

Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort.

Al Sawah S, Zhang X, Zhu B, Magder LS, Foster SA, Iikuni N, Petri M.

Lupus Sci Med. 2015 Mar 11;2(1):e000066. doi: 10.1136/lupus-2014-000066. eCollection 2015.

32.

The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease.

Trost LC, Rose ML, Khouri J, Keilholz L, Long J, Godin SJ, Foster SA.

Antiviral Res. 2015 May;117:115-21. doi: 10.1016/j.antiviral.2015.02.007. Epub 2015 Mar 4.

33.

The Effect of the Social and Physical Environment on Children's Independent Mobility to Neighborhood Destinations.

Christian HE, Klinker CD, Villanueva K, Knuiman MW, Foster SA, Zubrick SR, Divitini M, Wood L, Giles-Corti B.

J Phys Act Health. 2015 Jun 16;12 Suppl 1:S84-93. doi: 10.1123/jpah.2014-0271.

PMID:
25599389
34.

Multiple mechanisms determine the order of APC/C substrate degradation in mitosis.

Lu D, Hsiao JY, Davey NE, Van Voorhis VA, Foster SA, Tang C, Morgan DO.

J Cell Biol. 2014 Oct 13;207(1):23-39. doi: 10.1083/jcb.201402041. Epub 2014 Oct 6.

35.

A longitudinal analysis of the influence of the neighborhood built environment on walking for transportation: the RESIDE study.

Knuiman MW, Christian HE, Divitini ML, Foster SA, Bull FC, Badland HM, Giles-Corti B.

Am J Epidemiol. 2014 Sep 1;180(5):453-61. doi: 10.1093/aje/kwu171. Epub 2014 Aug 11.

36.

Knuiman et al. respond to "Time-varying neighborhood environments".

Knuiman MW, Christian HE, Divitini ML, Foster SA, Bull FC, Badland HM, Giles-Corti B.

Am J Epidemiol. 2014 Sep 1;180(5):467-8. doi: 10.1093/aje/kwu172. Epub 2014 Aug 11. No abstract available.

PMID:
25117658
37.

Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey.

Foster SA, Shortridge EF, DiBonaventura M, Viktrup L.

World J Urol. 2015 May;33(5):639-47. doi: 10.1007/s00345-014-1366-6. Epub 2014 Aug 7.

PMID:
25100623
38.

Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups.

Johns BA, Kawasuji T, Weatherhead JG, Boros EE, Thompson JB, Koble CS, Garvey EP, Foster SA, Jeffrey JL, Fujiwara T.

Bioorg Med Chem Lett. 2014 Jul 15;24(14):3104-7. doi: 10.1016/j.bmcl.2014.05.011. Epub 2014 May 16.

PMID:
24908608
39.

Erectile dysfunction with or without coexisting benign prostatic hyperplasia in the general US population: analysis of US National Health and Wellness Survey.

Foster SA, Annunziata K, Shortridge EF, Freedman D, Viktrup L.

Curr Med Res Opin. 2013 Dec;29(12):1709-17. doi: 10.1185/03007995.2013.837385. Epub 2013 Sep 23.

PMID:
23971532
40.

Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).

Johns BA, Kawasuji T, Weatherhead JG, Taishi T, Temelkoff DP, Yoshida H, Akiyama T, Taoda Y, Murai H, Kiyama R, Fuji M, Tanimoto N, Jeffrey J, Foster SA, Yoshinaga T, Seki T, Kobayashi M, Sato A, Johnson MN, Garvey EP, Fujiwara T.

J Med Chem. 2013 Jul 25;56(14):5901-16. doi: 10.1021/jm400645w. Epub 2013 Jul 11.

PMID:
23845180
41.

Reproductive success in a natural population of male three-spined stickleback Gasterosteus aculeatus: effects of nuptial colour, parasites and body size.

Sparkes TC, Rush V, Kopp DA, Foster SA.

J Fish Biol. 2013 May;82(5):1720-7. doi: 10.1111/jfb.12083. Epub 2013 Mar 27.

PMID:
23639166
42.

Osteoporosis and treatments in Japan: management for preventing subsequent fractures.

Nojiri S, Burge RT, Flynn JA, Foster SA, Sowa H.

J Bone Miner Metab. 2013 Jul;31(4):367-80. doi: 10.1007/s00774-013-0444-y. Epub 2013 Mar 28. Review.

PMID:
23536192
43.

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis.

Foster SA, Shi N, Curkendall S, Stock J, Chu BC, Burge R, Diakun DR, Krege JH.

BMC Womens Health. 2013 Mar 23;13:15. doi: 10.1186/1472-6874-13-15.

44.

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.

Hazel-Fernandez L, Louder AM, Foster SA, Uribe CL, Burge RT.

BMC Musculoskelet Disord. 2013 Jan 3;14:4. doi: 10.1186/1471-2474-14-4.

45.

Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groups.

Johns BA, Kawasuji T, Weatherhead JG, Boros EE, Thompson JB, Koble CS, Garvey EP, Foster SA, Jeffrey JL, Fujiwara T.

Bioorg Med Chem Lett. 2013 Jan 15;23(2):422-5. doi: 10.1016/j.bmcl.2012.11.071. Epub 2012 Dec 3.

PMID:
23245515
46.

The APC/C subunit Mnd2/Apc15 promotes Cdc20 autoubiquitination and spindle assembly checkpoint inactivation.

Foster SA, Morgan DO.

Mol Cell. 2012 Sep 28;47(6):921-32. doi: 10.1016/j.molcel.2012.07.031. Epub 2012 Aug 30.

47.

Budget impact analysis of insulin therapies and associated delivery systems.

Lee LJ, Smolen LJ, Klein TM, Foster SA, Whiteman D, Jorgenson JA, Hultgren S.

Am J Health Syst Pharm. 2012 Jun 1;69(11):958-65. doi: 10.2146/ajhp110333.

PMID:
22610028
48.

Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization.

Bergenstal RM, Fahrbach JL, Iorga ŞR, Fan Y, Foster SA.

Endocr Pract. 2012 May-Jun;18(3):371-5. doi: 10.4158/EP11166.OR.

PMID:
22548941
49.

The impact of teriparatide adherence and persistence on fracture outcomes.

Yu S, Burge RT, Foster SA, Gelwicks S, Meadows ES.

Osteoporos Int. 2012 Mar;23(3):1103-13. doi: 10.1007/s00198-011-1843-3. Epub 2011 Dec 8.

PMID:
22159748
50.

Ubiquitination of Cdc20 by the APC occurs through an intramolecular mechanism.

Foe IT, Foster SA, Cheung SK, DeLuca SZ, Morgan DO, Toczyski DP.

Curr Biol. 2011 Nov 22;21(22):1870-7. doi: 10.1016/j.cub.2011.09.051. Epub 2011 Nov 10.

Supplemental Content

Loading ...
Support Center